Insider trade

Avita Medical (RCEL)CFO bought ~$6K

David D O'toole, CFO at Avita Medical, bought ~$6K of Avita Medical shares.

~$6K
Approx. value · 475 sh @ $12.53
23K
Holds after · shares reported
Traded
Dec 5, 2024
Filed
Dec 5, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 5, 2024 · this disclosureInsiderCFO purchased ~$6K of RCEL shares in the open market

What came next

  1. Dec 5, 2024InsiderCFO purchased ~$6.2K of RCEL shares in the open market
  2. Dec 9, 2024InsiderDirector purchased ~$6.4K of RCEL shares in the open market
  3. Feb 19, 2025InsiderCFO purchased ~$10K of RCEL shares in the open market
  4. Feb 20, 2025Insider · 2 peopleInsiders: 2 purchases (~$111K)
  5. Mar 6, 2025InsiderDirector purchased ~$91K of RCEL shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Avita Medical

For Avita Medical, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RCEL page.

Other recent filings by David D O'toole, CFO

The full history of David D O'toole, CFO is on the profile page.

How this filing works

Other disclosures at Avita Medical

Everything OQRO holds on this company is on its RCEL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data